UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ion chromatographic determination of the cations of the elements of the third main and subgroup

Nitsch, Alfred

1991

Volltextzugriff (PDF)

Schwermetalle in Tabaken und Tabakrauch. I: Eine kompakte Laborrauchmaschine zum Abrauchen von Zigaretten und Zigarren

Fresenius' Zeitschrift für analytische Chemie, 1988, Vol.332 (1), p.17-21

1988

Volltextzugriff (PDF)

Digitally-controlled timing devices—a simple smoking machine

Computers & chemistry, 1990, Vol.14 (1), p.1-28

1990

Volltextzugriff (PDF)

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Nature (London), 2016-09, Vol.537 (7618), p.50-56

2016

Volltextzugriff (PDF)

Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old

Neurobiology of aging, 2018-04, Vol.64, p.68-75

2018

Volltextzugriff (PDF)

Same Same But Different: Dialects and Trade

German economic review (Oxford), 2015-08, Vol.16 (3), p.290-306

2015

Volltextzugriff (PDF)

Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab

Alzheimer's & dementia, 2024-05, Vol.20 (5), p.3406-3415

2024

Volltextzugriff (PDF)

Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia

Brain and behavior, 2020-06, Vol.10 (6), p.e01632-n/a

2020

Volltextzugriff (PDF)

Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe

The European journal of neuroscience, 2003-03, Vol.17 (6), p.1296-1302

2003

Volltextzugriff (PDF)

Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease

Alzheimer's research & therapy, 2017-03, Vol.9 (1), p.24-24, Article 24

2017

Volltextzugriff (PDF)

Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adults

Neurobiology of aging, 2018-03, Vol.63, p.152-161

2018

Volltextzugriff (PDF)

Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner

Neurobiology of aging, 2015-04, Vol.36 (4), p.1619-1628

2015

Volltextzugriff (PDF)

Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β–related cognitive decline

Neurobiology of aging, 2019-04, Vol.76, p.181-193

2019

Volltextzugriff (PDF)

Landscape of antibody immunotherapy for Alzheimer’s disease

Neurobiology of aging, 2016-03, Vol.39, p.S25-S26

2016

Volltextzugriff (PDF)

Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individuals

The European journal of neuroscience, 2017-05, Vol.45 (10), p.1241-1251

2017

Volltextzugriff (PDF)

Brain areas with normatively greater cerebral perfusion in early life may be more susceptible to beta amyloid deposition in late life

Cerebral circulation - cognition and behavior, 2020, Vol.1, p.100001, Article 100001

2020

Volltextzugriff (PDF)

Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar System

Frontiers in aging neuroscience, 2014-03, Vol.6, p.52-52

2014

Volltextzugriff (PDF)

Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Nature (London), 2017-06, Vol.546 (7659), p.564-564

2017

Volltextzugriff (PDF)

Aducanumab 36-month data from PRIME: a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.004)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Aducanumab titration dosing regimen: 24-month analysis from PRIME, a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.003)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

CLINICAL DEMENTIA RATING-SUM OF BOXES RESPONDER ANALYSIS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI-AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037)

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P416-P416

2016

Volltextzugriff (PDF)

Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects

Frontiers in aging neuroscience, 2014-09, Vol.6, p.240-240

2014

Volltextzugriff (PDF)

Interim Analyses of Fixed-Dose and Titration Cohorts from PRIME: A Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Aducanumab (S9.006)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

GABA and glutamate associate with evidence of preclinical Alzheimer disease in humans: A 7 Tesla MRSI and 11 C‐PIB PET study: Neuroimaging / Optimal neuroimaging measures for early detection

Alzheimer's & dementia, 2020-12, Vol.16 (S5)

2020

Volltextzugriff (PDF)

GABA and glutamate associate with evidence of preclinical Alzheimer disease in humans: A 7 Tesla MRSI and 11C‐PIB PET study

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ion chromatographic determination of the cations of the elements of the third main and subgroup

Schwermetalle in Tabaken und Tabakrauch. I: Eine kompakte Laborrauchmaschine zum Abrauchen von Zigaretten und Zigarren

Digitally-controlled timing devices—a simple smoking machine

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old

Same Same But Different: Dialects and Trade

Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab

Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia

Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe

Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease

Brain amyloid burden and cerebrovascular disease are synergistically associated with neurometabolism in cognitively unimpaired older adults

Regional cerebral blood flow estimated by early PiB uptake is reduced in mild cognitive impairment and associated with age in an amyloid-dependent manner

Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β–related cognitive decline

Landscape of antibody immunotherapy for Alzheimer’s disease

Hippocampal shape alterations are associated with regional Aβ load in cognitively normal elderly individuals

Brain areas with normatively greater cerebral perfusion in early life may be more susceptible to beta amyloid deposition in late life

Cortical Amyloid Beta in Cognitively Normal Elderly Adults is Associated with Decreased Network Efficiency within the Cerebro-Cerebellar System

Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease

Aducanumab 36-month data from PRIME: a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.004)

Aducanumab titration dosing regimen: 24-month analysis from PRIME, a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.003)

CLINICAL DEMENTIA RATING-SUM OF BOXES RESPONDER ANALYSIS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI-AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037)

Regional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects

Interim Analyses of Fixed-Dose and Titration Cohorts from PRIME: A Randomized, Double-Blind, Placebo-Controlled Phase 1b Study of Aducanumab (S9.006)

GABA and glutamate associate with evidence of preclinical Alzheimer disease in humans: A 7 Tesla MRSI and 11 C‐PIB PET study: Neuroimaging / Optimal neuroimaging measures for early detection

GABA and glutamate associate with evidence of preclinical Alzheimer disease in humans: A 7 Tesla MRSI and 11C‐PIB PET study

Suchergebnisse filtern